In this episode of our mPower podcast, Shelley Callahan is joined by Mitchell's third party subject-matter expert, Chris Williamson, to learn more about the current trends and challenges in the third party market. They'll also discuss successful strategies that top-performing claims organizations are incorporating, as well as why it's crucial for organizations to secure the right third party claims foundations first in order to achieve organizational success.
There’s a heightened awareness in our industry on how psychosocial factors impact an injured employee’s recovery. But what’s the best way to approach and address these issues? In the fourth and final installment of our mental health in comp podcast series, we ask Nikki Wilson and Tammy Bradly to share some best practices.
None of us have gone untouched by the COVID-19 pandemic. This is especially true for frontline workers who care for the critically ill. So, in part three of our series on mental health’s impact on workers’ comp, we’re going to look at the psychosocial effects the pandemic continues to play on our society and how post-traumatic stress disorder (PTSD) has become a term used more often in our industry.
In part two of our mental health podcast series, we ask Tammy Bradly and Mariellen Blue if addressing mental health in the initial assessment and throughout the claim can actually have a positive effect on claims management.
In this episode, we sit down with Mitchell | Genex | Coventry experts Mariellen Blue, National Director of Case Management Services at Genex, Tammy Bradly, Vice President, Clinical Production Development at Coventry, and Nikki Wilson, Director, Pharmacy Product Development at Mitchell, to discuss the role mental health plays in workers' comp and the misconceptions around treating mental health conditions.
This episode is episode one of a four part series.
In 2020, the workers’ compensation and auto casualty regulatory environment was more active than ever—since the start of the COVID-19 pandemic, U.S. states have passed a multitude of executive actions and emergency regulations. As we look ahead to 2021, the industry will start to see the long-term effects of these new COVID-19 regulations. Listen to our podcast to hear our legislative and regulatory predictions for 2021.
As states continue to legalization medical and recreational marijuana, what impact might the workers’ compensation industry experience? Join us for this exciting webinar as VP of Government Affairs, Brian Allen, walks you through the latest in marijuana legislation and how it could affect workers’ compensation. Attendees will learn how various states are handling the legalization of the drug, how the drug might be used for treatment by workers’ compensation patients, and how insurers should respond on a state-by-state basis.
In this episode, we sat down with Michele Hibbert-Iacobacci, Mitchell senior vice president of regulatory compliance management, to learn more about COVID-19 and related social distancing guidelines are affecting the auto casualty insurance industry. Listen to learn more about changing claim frequency and duration, the effects of delayed care for injured claimants and regulatory updates.
In this podcast, hear from Genex Senior Vice President of National Accounts and Marketing Pat Chavanu about how the COVID-19 pandemic has caused case managers to shift and think outside of the box. Chavanu outlines some of the concerns the workers’ compensation industry is facing today and provides examples of how case managers are working to help injured workers get the care they need.
Mitchell Senior Vice President of Regulatory Compliance Management Michele Hibbert-Iacobacci explains how the COVID-19 pandemic has affected the workers’ compensation industry so far, and explains potential lasting market impacts. In this podcast, hear more about regulatory changes, the effects of delayed care and how telemedince is playing a role.
In this episode, we discussed the potential impact of COVID-19 on pharmacy-related issues in workers' compensation. Learn more from Chief Clinical Officer, Dr. Mitch Freeman.
